Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goodfire is an AI research lab and software company specializing in mechanistic interpretability, a field dedicated to understanding and controlling the internal workings of complex neural networks. The company's flagship platform, Ember, allows researchers and developers to decode and edit the internal representations of AI models, transforming them from 'black boxes' into transparent, steerable systems. In the life sciences, Goodfire has demonstrated the power of its technology by reverse-engineering biological foundation models to discover novel scientific insights, such as identifying a new class of Alzheimer's biomarkers in collaboration with partners like the Mayo Clinic and Arc Institute. Founded by a team of experts from OpenAI and Google DeepMind, Goodfire operates as a Public Benefit Corporation and is backed by over $200 million in venture capital to bridge the gap between AI development and scientific discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goodfire.